M&G plc NEWS RELEASE
22 May 2024
M&G plc
Notification of transactions by Person Discharging Managerial Responsibilities ('PDMR')
On 21 May 2024, M&G plc was informed of changes to the interests in M&G plc shares of Benoît Macé following the reinvestment of the recent interim dividend payment of 13.2 pence per share on his personal shareholdings.
The notification below, made in accordance with the requirements of the Market Abuse Regulation, provides further detail.
Contact
Christopher Smyth, Director of Secretariat - 020 8162 0527
Sharna Ludlow, Head of Share Plans and Share Registration - 020 8162 0611
1
| Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Benoît Macé | ||||
2 | Reason for the notification | |||||
a) | Position/status | Chief Strategy & Transformation Officer | ||||
b) | Initial notification/Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | M&G plc | ||||
b) | LEI | 254900TWUJUQ44TQJY84 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 5 pence each
| ||||
b) | Nature of the transaction | Acquisition of shares through reinvested dividends under personal shareholding
| ||||
c) | Price(s) and volume(s) |
| ||||
| Aggregated information
-Aggregated volume
-Price |
5,747
£2.11 | ||||
| Date of the transaction | 2024-05-16 | ||||
| Place of the transaction | XLON |
LEI: 254900TWUJUQ44TQJY84
Classification: 2.2 Information disclosed under article 19 of the Market Abuse Regulation.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.